Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2464605016 | Tositumomab 14mg/mL/Iodine 131 5.6mCi/mL/Tositumomab 1.1mg/mL injection vial (product) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2470965011 | Tositumomab 14mg/mL/Iodine 131 5.6mCi/mL/Tositumomab 1.1mg/mL injection vial | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tositumomab 14mg/mL/Iodine 131 5.6mCi/mL/Tositumomab 1.1mg/mL injection vial (product) | est un(e) (attribut) | Product containing tositumomab (medicinal product) | false | Inferred relationship | Some | ||
| Tositumomab 14mg/mL/Iodine 131 5.6mCi/mL/Tositumomab 1.1mg/mL injection vial (product) | est un(e) (attribut) | Product containing iodine-131 (medicinal product) | false | Inferred relationship | Some | ||
| Tositumomab 14mg/mL/Iodine 131 5.6mCi/mL/Tositumomab 1.1mg/mL injection vial (product) | a pour principe actif (attribut) | Iodine radioisotope | false | Inferred relationship | Some | ||
| Tositumomab 14mg/mL/Iodine 131 5.6mCi/mL/Tositumomab 1.1mg/mL injection vial (product) | a pour principe actif (attribut) | Immunosuppressant (substance) | false | Inferred relationship | Some | ||
| Tositumomab 14mg/mL/Iodine 131 5.6mCi/mL/Tositumomab 1.1mg/mL injection vial (product) | a pour principe actif (attribut) | tositumomab | false | Inferred relationship | Some | ||
| Tositumomab 14mg/mL/Iodine 131 5.6mCi/mL/Tositumomab 1.1mg/mL injection vial (product) | a une forme pharmaceutique (attribut) | Injection | false | Inferred relationship | Some | ||
| Tositumomab 14mg/mL/Iodine 131 5.6mCi/mL/Tositumomab 1.1mg/mL injection vial (product) | a pour principe actif (attribut) | Radiopharmaceutical agent (substance) | false | Inferred relationship | Some | ||
| Tositumomab 14mg/mL/Iodine 131 5.6mCi/mL/Tositumomab 1.1mg/mL injection vial (product) | a pour principe actif (attribut) | Iodine-131 (substance) | false | Inferred relationship | Some | ||
| Tositumomab 14mg/mL/Iodine 131 5.6mCi/mL/Tositumomab 1.1mg/mL injection vial (product) | est un(e) (attribut) | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
FHIR